Please use this identifier to cite or link to this item:
https://rsuir-library.rsu.ac.th/handle/123456789/2733Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Wanida Limpongsanurak | - |
| dc.contributor.author | Kiattisak Santipas | - |
| dc.date.accessioned | 2025-01-29T05:57:18Z | - |
| dc.date.available | 2025-01-29T05:57:18Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.uri | https://rsuir-library.rsu.ac.th/handle/123456789/2733 | - |
| dc.description | Thesis (M.S. (Dermatology and Dermatosurgery)) -- Rangsit University, 2023 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Rangsit University | en_US |
| dc.subject | Phototherapy | en_US |
| dc.subject | Photosensitivity Disorders | en_US |
| dc.subject | Psoralen plus | en_US |
| dc.title | Phototoxic reaction complicated from phototherapy in Thai patients with dermatological diseases : a retrospective study | en_US |
| dc.type | Thesis | en_US |
| dc.description.other-abstract | The phototoxic reaction is one of phototherapy's most significant adverse effects. This retrospective, single-center study in the dermatology department aims to describe the prevalence of phototoxic reactions related to phototherapy in Thai patients. All phototherapy patients in this study had 64,629 collective sessions between October 2015 and September 2020. The 200 sessions (0.3%) with phototoxic responses were associated with phototherapy. The dermatosis with the most significant incidence of phototoxic reactions was vitiligo (54%). The most common cause of phototoxicity stemmed from patient variables, including compliance issues such as excessive exposure to sunlight (9% ), medication (8 .5% ), loss of treatment (6% ), underwear displacement from the previous visit (2 .5 % ), rubbing the lesion (2.5%), wearing various protective sizes (2.5%), failure to apply sunscreen (2%) concurrent disease (2% ), and unknown cause (16.5%). The subsequent treatment protocol was the most significant cause, accounting for 4 9 .5% . Technical error constituted the final 2.5%. The dermatologist needs to recognize when to continue increasing the dose and to emphasize to the patient they must comply with the treatment. | en_US |
| dc.description.degree-name | Master of Science | en_US |
| dc.description.degree-level | Master's Degree | en_US |
| dc.contributor.degree-discipline | Dermatology and Dermatosurgery | en_US |
| Appears in Collections: | Med-DD-M-Thesis | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| KIATTISAK SANTIPAS.pdf | 783.72 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.